Novo Nordisk
NVO
#78
Rank
โ‚ฌ182.65 B
Marketcap
41,11ย โ‚ฌ
Share price
-0.27%
Change (1 day)
-60.08%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚ฌ22.94 Billion

According to Novo Nordisk's latest financial reports the company has โ‚ฌ22.94 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novo Nordisk - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚ฌ19.23 B34.76%
2023-12-31$โ‚ฌ14.27 B27.38%
2022-12-31$โ‚ฌ11.20 B17.85%
2021-12-31$โ‚ฌ9.51 B11.76%
2020-12-31$โ‚ฌ8.51 B10.4%
2019-12-31$โ‚ฌ7.70 B11.03%
2018-12-31$โ‚ฌ6.94 B3.73%
2017-12-31$โ‚ฌ6.69 B9.84%
2016-12-31$โ‚ฌ6.09 B-3.2%
2015-12-31$โ‚ฌ6.29 B16.34%
2014-12-31$โ‚ฌ5.41 B-5.18%
2013-12-31$โ‚ฌ5.70 B4.78%
2012-12-31$โ‚ฌ5.44 B8.42%
2011-12-31$โ‚ฌ5.02 B1.29%
2010-12-31$โ‚ฌ4.95 B3.23%
2009-12-31$โ‚ฌ4.80 B8.2%
2008-12-31$โ‚ฌ4.44 B2.81%
2007-12-31$โ‚ฌ4.31 B6.67%
2006-12-31$โ‚ฌ4.04 B9.78%
2005-12-31$โ‚ฌ3.68 B2.98%
2004-12-31$โ‚ฌ3.58 B5.4%
2003-12-31$โ‚ฌ3.39 B0.06%
2002-12-31$โ‚ฌ3.39 B-3.68%
2001-12-31$โ‚ฌ3.52 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
โ‚ฌ79.96 B 248.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ20.48 B-10.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ15.97 B-30.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ74.12 B 223.03%๐Ÿ‡ซ๐Ÿ‡ท France